International Journal of Clinical Research

Objective To study the clinical efficacy of combined treatment with metoprolol and amiodarone for arrhythmia. Methods Ninety patients with arrhythmia who were treated in our hospital from August 2021 to August 2023 were selected and randomly divided into two groups using a digital random table method. The control group (treated with amiodarone) and the observation group (treated with metoprolol and amiodarone combination) each had 45 cases. Compare the therapeutic effects of different treatment plans on two groups of patients. Results Compared with the control group, the total effective rate of treatment in the observation group was significantly higher, and the data difference was statistically significant (P<0.05). The number of tachycardia attacks and ventricular premature contractions in the two groups after treatment was significantly reduced compared to before treatment. The number of attacks in the observation group after treatment was lower than that in the control group, with statistical significance (P<0.05); The QTs period after treatment in both groups increased compared to before treatment, and the QTs period after treatment in the observation group was higher than that in the control group, with statistical significance (P<0.05). Conclusion The combined treatment of metoprolol and amiodarone for patients with arrhythmia has a good effect and can effectively improve their cardiac function, which is beneficial for improving the therapeutic effect.

Arrhythmias; Metoprolol; Amiodarone; Curative effect